MORIERI, MARIO LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.208
EU - Europa 216
AS - Asia 147
OC - Oceania 3
AF - Africa 2
SA - Sud America 1
Totale 2.577
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.205
IT - Italia 128
CN - Cina 121
FI - Finlandia 21
GB - Regno Unito 21
SE - Svezia 15
DE - Germania 13
VN - Vietnam 12
IN - India 9
FR - Francia 5
IE - Irlanda 5
UA - Ucraina 5
AU - Australia 3
CA - Canada 3
GA - Gabon 2
SI - Slovenia 2
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 2.577
Salva come PNG Salva come JPEG
Città #
Fairfield 459
Chandler 238
Woodbridge 188
Ashburn 174
Houston 174
Cambridge 169
Seattle 158
Wilmington 126
San Diego 56
Ann Arbor 55
Medford 47
Princeton 47
Beijing 42
Des Moines 31
Roxbury 26
Helsinki 19
Padova 18
Dong Ket 11
New York 10
Cagliari 9
Guangzhou 9
Nanjing 9
London 8
Rome 6
Shanghai 6
Breganze 5
Los Angeles 5
Milan 5
Pescara 5
Pune 5
Redmond 5
Redwood City 5
Borås 4
Changsha 4
Dallas 4
Jinan 4
Nanchang 4
Norwalk 4
Paris 4
Vicenza 4
Boardman 3
Dublin 3
Florence 3
Ogden 3
Pravisdomini 3
Vicopisano 3
Zhengzhou 3
Acton 2
Agordo 2
Albignasego 2
Council Bluffs 2
Delhi 2
Duncan 2
Ferrara 2
Haikou 2
Hounslow 2
Jiujiang 2
Kharkiv 2
Lappeenranta 2
Libreville 2
Ljubljana 2
Massapequa 2
Modica 2
Naples 2
Ningbo 2
Ottawa 2
Paese 2
Pollenza 2
Rovigo 2
San Francisco 2
Taranto 2
Wandsworth 2
Ardabil 1
Bari 1
Bratislava 1
Brendola 1
Charlotte 1
Dearborn 1
Gravesend 1
Hamburg 1
Hebei 1
Hyderabad 1
Jakarta 1
Jiaxing 1
Kilburn 1
Launceston 1
Legnaro 1
Lima 1
Lonigo 1
Melbourne 1
Mestrino 1
Molise 1
New Delhi 1
Nuremberg 1
Piemonte 1
Pisa 1
Polesine 1
Pordenone 1
Prescot 1
Quezon City 1
Totale 2.261
Salva come PNG Salva come JPEG
Nome #
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study 115
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 101
Adipokines levels in HIV infected patients: Lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation 92
Computerized cognitive training and brain derived neurotrophic factor during bed rest: Mechanisms to protect individual during acute stress 89
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 86
Interleukin-6 "Trans-Signaling" and Ischemic Vascular Disease: The Important Role of Soluble gp130 85
Genetic tools for coronary risk assessment in type 2 diabetes: A cohort study from the ACCORD clinical trial 83
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 83
Insufficient Evidence for Interaction Between Haptoglobin Phenotypes and Intensive Glycemic Control on Cardiovascular Outcomes 82
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes 76
Genetic predictors of cardiovascular mortality during intensive glycemic control in type 2 diabetes: Findings from the ACCORD clinical trial 76
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysis 71
Brain-derived neurotrophic factor plasma levels: Relationship with dementia and diabetes in the elderly population 71
Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study 68
PPARA polymorphism influences the cardiovascular benefit of fenofibrate in type 2 diabetes: Findings from accord-lipid 61
Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes 61
Modulation of GLP-1 levels by a genetic variant that regulates the cardiovascular effects of intensive glycemic control in ACCORD 59
Trend 2010–2018 in the clinical use of GLP-1 receptor agonists for the treatment of type 2 diabetes in routine clinical practice: an observational study from Northeast Italy 59
Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics 59
Uric acid within the “normal” range predict 9-year cardiovascular mortality in older individuals. The InCHIANTI study 57
Long-acting injectable glp-1 receptor agonists for the treatment of adults with type 2 diabetes: Perspectives from clinical practice 55
Farmacogenetica del fenofibrato: verso una medicina di precisione nella prevenzione delle complicanze micro e macro-vascolari del diabete 50
Comparative effectiveness of dapagliflozin vs DPP-4 inhibitors on a composite endpoint of HbA1c, body weight, and blood pressure reduction in the real world 50
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage 50
Disease progression in HIV Late Presenters: The role of HIV clinical indicator diseases prior to HIV diagnosis 50
Prevalence and impact of diabetes among people infected with SARS-CoV-2 48
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care 48
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial 48
Combining LDL-C and HDL-C to predict survival in late life: The InChianti study 47
Variants in ANGPTL4 and the Risk of Coronary Artery Disease 46
Effectiveness of dulaglutide in the real world and in special populations of type 2 diabetic patients. 42
Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia 40
Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer's Disease 40
First case of 2 intraductal papillary mucinous tumors of both ventral and dorsal ducts in pancreas divisum 38
Association of Hypomorphic P2X7 Receptor Genotype With Age 38
PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome 36
Long-term cardiovascular outcome after intensive versus standard screening of diabetic complications: a real-word observational study 33
Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies. 33
The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy 32
Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study 31
In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational study 27
Gene expression regional differences in human subcutaneous adipose tissue 25
Performance assessment across different care settings of a heart failure hospitalisation risk-score for type 2 diabetes using administrative claims 21
Age-related differences in plasma BDNF levels after prolonged bed rest 19
Why diabetes outpatient clinics should not close during pandemic crises 19
Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults 19
Changes in markers of hepatic steatosis and fibrosis in patients with type 2 diabetes during treatment with glucagon-like peptide-1 receptor agonists. A multicenter retrospective longitudinal study 18
Explainable Deep-Learning Model Reveals Past Cardiovascular Disease in Patients with Diabetes Using Free-Form Visit Reports 13
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care 12
The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes 12
Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets’ attainment in subjects with and without type 2 diabetes 12
Performance assessment across different care settings of a heart failure hospitalisation risk-score for type 2 diabetes using administrative claims 9
Deviations from the ADA/EASD treatment algorithm is associated with higher cardiovascular events and death in type 2 diabetes under routine care 9
Time-series analysis of multidimensional clinical-laboratory data by dynamic Bayesian networks reveals trajectories of COVID-19 outcomes 9
Deciphering dementia in the cardiometabolic continuum 8
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes 7
Deep-learning-based natural-language-processing models to identify cardiovascular disease hospitalisations of patients with diabetes from routine visits' text 3
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history 3
Heart Failure Burden in Diabetes: Can Fenofibrate Provide Additional Hope? 3
Prevalence and risk factors of glomerular hyperfiltration in adults with type 2 diabetes: A population-based study 3
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus 2
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 2
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells 2
Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies 1
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care 1
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus 1
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus 1
Totale 2.650
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.222
article - articoli 12.644
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201921 0 0 0 0 0 0 0 0 0 0 4 17
2019/2020366 25 30 0 53 33 17 37 41 45 42 28 15
2020/2021868 21 10 58 37 340 41 60 63 84 32 83 39
2021/2022612 39 49 53 18 50 73 18 52 78 16 36 130
2022/2023468 91 64 17 43 62 46 6 37 56 8 30 8
2023/2024310 17 48 20 28 21 47 62 17 15 24 11 0
Totale 2.650